Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines
An IASLC survey showed that molecular testing is not performed in line with expert guidelines, which means only a minority of lung cancer patients are benefitting from precision oncology.
Delayed Testing, Limited Patient Understanding May Hinder Precision Oncology Access, Survey Suggests
The survey results point to the need for greater education among patients so they can better advocate for themselves.
2018 GenomeWeb Salary Survey
Respondents to GenomeWeb's salary survey reported variations in their salaries that varied by sector.
Survey Finds QC Best Practices in Clinical Genomics Still Developing
The survey, conducted by SeraCare Life Sciences and GenomeWeb, asked more than 150 individuals working on clinical NGS about their quality control practices.
Public Awareness of Personalized Medicine Not Growing in Step With Industry, Survey Shows
Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving.